Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudi Beyaert

Showing results (31-40 of 231) with videos related to

Pageof 24
Sort By:
Biochemical and Biophysical Research Communications|August 2, 2008
Smurf2 is a TRAF2 binding protein that triggers TNF-R2 ubiquitination and TNF-R2-induced JNK activationIsabelle Carpentier, Beatrice Coornaert, Rudi Beyaert
The Journal of Biological Chemistry|November 15, 2008
A20: central gatekeeper in inflammation and immunityBeatrice Coornaert, Isabelle Carpentier, Rudi Beyaert
Cell Death and Differentiation|April 1, 2017
CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so differentMarie Lork, Kelly Verhelst, Rudi Beyaert
Current Protein & Peptide Science|January 12, 2013
Structure and function of the Type III secretion system of Pseudomonas aeruginosaMarlies Galle, Isabelle Carpentier, Rudi Beyaert
Cellular Immunology|December 6, 2018
Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cellsMarie Lork, Jens Staal, Rudi Beyaert
Advances in Experimental Medicine and Biology|October 11, 2014
The biology of A20-binding inhibitors of NF-kappaB activation (ABINs)Lynn Verstrepen, Isabelle Carpentier, Rudi Beyaert
Trends in Immunology|August 1, 2009
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathologyLars Vereecke, Rudi Beyaert, Geert van Loo
Expert Opinion on Therapeutic Targets|September 23, 2009
Targeting the EGF receptor ectodomain in the context of cancerLieven Huang, Patrick De Baetselier, Rudi Beyaert
Trends in Molecular Medicine|July 12, 2011
Enterocyte death and intestinal barrier maintenance in homeostasis and diseaseLars Vereecke, Rudi Beyaert, Geert van Loo
Biochemical Pharmacology|August 29, 2021
Polo-like kinase 1 (PLK1) signaling in cancer and beyondStyliani Iliaki, Rudi Beyaert, Inna S Afonina
Pageof 24

Showing results (31-40 of 231) with videos related to

Sort By:
Pageof 24
Biochemical and Biophysical Research Communications|August 2, 2008
Smurf2 is a TRAF2 binding protein that triggers TNF-R2 ubiquitination and TNF-R2-induced JNK activationIsabelle Carpentier, Beatrice Coornaert, Rudi Beyaert
The Journal of Biological Chemistry|November 15, 2008
A20: central gatekeeper in inflammation and immunityBeatrice Coornaert, Isabelle Carpentier, Rudi Beyaert
Cell Death and Differentiation|April 1, 2017
CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so differentMarie Lork, Kelly Verhelst, Rudi Beyaert
Current Protein & Peptide Science|January 12, 2013
Structure and function of the Type III secretion system of Pseudomonas aeruginosaMarlies Galle, Isabelle Carpentier, Rudi Beyaert
Cellular Immunology|December 6, 2018
Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cellsMarie Lork, Jens Staal, Rudi Beyaert
Advances in Experimental Medicine and Biology|October 11, 2014
The biology of A20-binding inhibitors of NF-kappaB activation (ABINs)Lynn Verstrepen, Isabelle Carpentier, Rudi Beyaert
Trends in Immunology|August 1, 2009
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathologyLars Vereecke, Rudi Beyaert, Geert van Loo
Expert Opinion on Therapeutic Targets|September 23, 2009
Targeting the EGF receptor ectodomain in the context of cancerLieven Huang, Patrick De Baetselier, Rudi Beyaert
Trends in Molecular Medicine|July 12, 2011
Enterocyte death and intestinal barrier maintenance in homeostasis and diseaseLars Vereecke, Rudi Beyaert, Geert van Loo
Biochemical Pharmacology|August 29, 2021
Polo-like kinase 1 (PLK1) signaling in cancer and beyondStyliani Iliaki, Rudi Beyaert, Inna S Afonina
Pageof 24